MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Hologic revenues rise 4.4% during fiscal third quarter

Hologic revenues rise 4.4% during fiscal third quarter

By

HOLX logo

Diagnostic equipment provider Hologic Inc. (NSDQ:HOLX) reported adjusted net earnings of $78.2 million, of 30 cents per share, on $420.7 million in revenues, generally in line with Wall Street expectations but falling short of year-ago profit comparisons.

Including amortization costs and charges related to accounting changes at the Bedford, Mass.-based company, net income during the three months ended June 26 was $27.4 million, down from a $30.8 million profit in the year-ago quarter.

Revenues climbed 4.4 percent during Hologic’s fiscal third quarter. The gains were supported by 8.3 percent growth in breast health revenues, primarily due to added numbers of installed Selenia digital mammography systems, coupled with an 8.7 percent jump in GYN surgical revenues. Sales within the diagnostics and skeletal health segments both fell slightly during the quarter.

The company also said Tuesday that its Selenia Dimensions 3-D digital breast tomosynthesis system has been scheduled for a Sept. 24 review by the FDA’s Radiological Devices Panel. Hologix applied for pre-market approval for the device by the U.S. Food and Drug Administration two years ago, seeking approval for both screening and diagnostic use.

During a conference call with analysts Tuesday night, Hologic CEO Robert Cascella described the upcoming review as “a very, very encouraging sign” and stuck with the company’s previous forecast for a 2011 launch but also cautioned against believing approval is a foregone conclusion.

He also said the company — based on its experience bringing the 3-D system to market in Europe — would expect still-unspecified ramp-up expenses connected with an U.S. launch, including costs educating radiologists on how to read tomosynthesis results. “There’s much more sales training that will go into it,” he explained. “But the true incremental cost will be physician training.”

Hologic increased its fiscal 2010 revenue guidance by $5 million to a new range between $1.665 billion to $1.670 billion, reflecting the current level of capital equipment stabilization during the first nine months of fiscal 2010.

In case you missed it

RSS From Medical Design & Outsourcing

  • Owens & Minor and Allina Health partner on supply chain resiliency
    Owens & Minor (NYSE: OMI) and Minneapolis-based Allina Health are partnering on what they call a “unique integrated service model for supply chain resiliency.” An Owens & Minor distribution center that has been in operation for more than 25 years in Moundsview, Minnesota will serve as the integrated service center powering the model, the companies… […]
  • Chronic pain researchers say sound and electrical stimulation has treatment potential
    University of Minnesota researchers are using sound and electrical stimulation to treat chronic pain and other sensory disorders without pharmaceutical drugs. The combination of sound and stimulation activates the brain’s somatosensory cortex, according to a study on guinea pigs published in the Journal of Neural Engineering. Also known as the tactile cortex, the somatosensory cortex is… […]
  • What Laura Mauri learned from a ‘firestorm’ in her first months at Medtronic
    Dr. Laura Mauri faced a monumental moment with former Medtronic CEO Omar Ishrak shortly after she joined the company as VP of global clinical research and analytics. It was late 2018, and Mauri — who’s now an SVP and the chief scientific, medical and regulatory officer at Medtronic (NYSE: MDT) — was in a meeting… […]
  • Senators seek post-market FDA study of pulse oximeters and skin color
    Democratic U.S. senators are prodding the FDA to launch a post-market study of pulse oximeters due to unreliable performance for patients with dark skin. Pulse oximeters estimate blood oxygen levels (SpO2) and pulse rates in patients using infrared light — usually on a fingertip — at home or in clinical settings. Blood oxygenation is one… […]
  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]

Leave a Reply